Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Signs up Asia Pacific Distributor

NEW YORK (GenomeWeb News) – Molecular diagnostics company Response Genetics said today that it has tapped the Australian firm Genetic Technologies to distribute three of its oncology testing panels in Southeast Asia and in Australia.

The agreement makes Genetic Technologies the exclusive distributor for the three ResponseDX tests, including the Colon, Lung, and Gastric genetic panels, in Australia, Indonesia, Malaysia, the Philippines, Singapore, and Thailand.

The ResponseDX tests are PCR-based and they analyze gene expression in tumors that correlate with common chemotherapy drugs.

"Based on encouraging sales and rapid adoption here in the Unites States, we have embarked on a growth strategy focused on expanding the availability of our tests in additional markets," Response Genetics CEO Kathleen Danenberg said in a statement.

All of Los Angeles-based Response Genetics' tests are performed through its CLIA-certified lab, and through clinical reference lab NeoGenomics Laboratories.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.